Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
You can register here.
UMC Utrecht takes third surgical robot into use
UMC Utrecht has commissioned a third surgical robot. With the arrival of the latest generation, the Da Vinci 5, even more patients can be operated on with minimal stress. This leads to fewer complications and faster recovery. “Apart from the benefits for patients, the Da Vinci 5 also allows us to train even better,” says Jelle Ruurda, gastrointestinal surgeon and professor of robot-assisted minimally invasive surgery. “At the touch of a button, colleagues can watch remotely, and even learn from previous operations. This way we share knowledge faster and more widely.” The hospital is thus building on a tradition of 25 years at the forefront of robotic surgery.
The HU ORM program is moving to the Utrecht Science Park.
The Entrepreneurship & Retail Management (ORM) program will relocate from Amersfoort to the Utrecht Science Park as of September 1, 2026. According to program manager Lisette Luijk (Institute for Marketing & Commerce), it is mainly about one thing: more connection.
Danny Sahtoe receives NVBMB prize
Danny Sahtoe has been awarded the prestigious NVBMB prize, a prize that gives recognition to the work of a highly talented young independent researcher in the field of biochemistry or molecular biology. The prize includes funding to organize a one-day symposium on a topic of choice. Danny Sahtoe is group leader at the Hubrecht Institute and Investigator at Oncode Institute.
Inspiring and connecting visit by the President of Estonia to Utrecht Science Park
On Wednesday, April 8, 2026, the President of Estonia, Mr. Alar Karis, together with his wife Sirje Karis, ambassador Mr. Paul Teesalu and a delegation from the Estonian Health Ecosystem, visited the Utrecht Science Park. During the visit, much knowledge was exchanged and valuable connections were made.